Clinical trial
Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors
NCT00240461 · Capital Health, Canada, Other · Completed
Key facts
| NCT number | NCT00240461 |
|---|---|
| Title | Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors |
| Official title | Efficacy and Safety of COLD-fX in the Prevention of Respiratory Infections in Community-dwelling Seniors: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial |
| Lead sponsor | Capital Health, Canada, Other |
| Collaborators | Afexa Life Sciences Inc Industry IWK Health Centre Sunnybrook Health Sciences Centre Erasmus Medical Center University of BC Gerontology & Diabetes Research |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Tract Infection |
| Intervention type | Dietary Supplement, Other |
| Interventions | COLD-fX natural health product, COLD-fX, Placebo |
| Enrollment | 780 |
| Start date | Sep 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Oct 18, 2005 |
| Last update posted | Jul 7, 2011 |
| Countries | Canada, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: